Clinical significance of p53, nm23, and bcl-2 in T3-4 N1M0 oesophageal carcinoma: An immunohistochemical approach

Journal of Surgical Oncology

Volumn 65, Issue 2, 1997, Pages 111-116

  Patel, Devendra D ^a   Bhatavdekar, Jyotsna M ^a   Chikhlikar, Priya R ^a   Patel, Yatin V ^a   Shah, Neelam G ^a   Ghosh, Nandita ^a   Suthar, Tejal P ^a   Balar, Damodar B ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

bcl 2; nm23; Oesophageal carcinoma; p53; Prognosticator

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030744389     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199706)65:2<111::AID-JSO7>3.0.CO;2-A     Document Type: Article

References (21)

1. Tsujinaka T, Shiozaki H, Kido Y, et al.: Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy for inoperable squamous cell carcinoma of the esophagus potentially followed by surgery. J Surg Oncol 1995;58:50-56.
2. Fink U, Stein HJ, Wilke H, et al.: Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995;19:198-204.
3. Vokes EE, Weichsbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 1993;328:184-194.
4. Nigro JM, Baker SJ, Preisinger AC, et al.: Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-708.
5. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic-basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 1991;88:5006-5010.
6. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 1991;351:453-456.
7. Sidransky D, Von Eschenbach A, Tsai YC, et al.: Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-709.
8. Lane DP: p53, guardian of the genome. Nature 1992;358:15-16.
9. Thor AD, Moore DH II, Edgerton SM, et al.: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-855.
10. Barnes DM, Dublin EA, Fischer CJ, et al.: Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis. Human Pathol 1993;24: 469-476.
11. Lam KY, Loke SL, Chen WZ, et al.: Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. Eur J Surg Oncol 1995;21:242-247.
12. Royds JA, Stephenson TJ, Rees RC, et al.: Nm23 product expression in in-situ and invasive human breast cancer. J Natl Cancer Inst 1993;85:727-731.
13. Royds JA, Cross SS, Silcocks PB, et al.: Nm23 "anti-metastatic" gene product expression in colorectal carcinoma. J Pathol 1994; 172:261-266.
14. Hockenbery DM, Zutter M, Hickey W, et al.: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965.
15. LeBrun DP, Warnke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993;142: 743-753.
16. Lu Q-L, Poulson R, Wong L, Hanby A: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993;169: 431-437.
17. UICC TNM classification of malignant tumours. UICC Technical Report Series 1980;51:8.
18. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
19. Pearson ES, Hartley HO: Approximate significance tests for contingency tables. In Matthews DE, Farewell VT (eds): "Using and Understanding Medical Statistics." Switzerland: Karger, 1988, p 39-53.
20. Sarbia M, Porchen R, Borchard F, et al.: p53 protein expression and prognosis in squamous cell carcinoma of esophagus. Cancer 1994;74:2218-2223.
21. Lauwers GY, Scott GV, Karpeh MS: Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995;75:2209-2213.